Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems

Hematology and Cell Therapy

Volumn 39, Issue 2, 1997, Pages 67-73

  Feugier, P ^a   Thevenin S ^b   Billot, M ^b   Serrurier, B ^a   Loigerot, C ^a   Schooneman, F ^a   Janot, C ^a   Herve P ^b   Racadot, E ^b  

^a Site de Nancy   (France)

^b Etablissement Transfus Sang F   (France)

Author keywords

hematopoietic stem cells; T cell depletion

Indexed keywords

ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL SEPARATION; CONTROLLED STUDY; HUMAN; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0030811070     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0067-7     Document Type: Article

References (26)

1. Cottler-Fox M, Cipolone K, Yu M, et al (1995) Positive selection of CD34 positive hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp Hematol 23: 320-322
2. De Witte T, Raymakers R, Plas A, et al (1984) Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation 37: 151-155
3. Dreger P, Viehmann K, Steinmann J, et al (1995) G-CSF-mobilized blood progenitor wells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34 positive selection systems or Campath-1. Exp Hematol 23: 147-154
4. Ferrara JLM, Deeg HJ (1991) Graft versus host disease. N Engl J Med 324: 667-674
5. Filipovitch AH, Vallera D, Mc Glave P, et al (1990) T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. Transplantation 50: 410-415
6. Frame JN (1989) T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation 47: 984-988
7. Gao IK, Noga SJ, Wagner JE, et al (1987) Implementation of a semiclosed large scale counterflow centrifugal elutriation system. J Clin Apheresis 3: 154-160
8. •etic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Eng J Med 321: 1174-1178
9. Goldman JM, Gale RP, Horowitz MM, et al (1988) Bone marrow transplantation for chronic myeloïd leukemia in chronic phase. Ann Intern Med 108: 806-814
10. Hale G, Waldmann H (1994) Control of graft versus host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases. Bone marrow transplant 13: 597-611
11. Hercend T, Takvorian T, Nowill A, et al (1986) Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 67: 722-726
12. Jansen J, Hanks S, English D, et al (1992) Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts. In: Worthington-White DA, Gee AP, Gross S (eds) Advances in bone marrow purging and processing, Wiley-Liss, New York, p 405-410
13. Kernan N, Collins NH, Juliano L, et al (1986) Clonable T lymphocytes in T cell depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 68: 770-773
14. O'Reilly RJ (1992) T-cell depletion and allogeneic bone marrow transplantation. Semin Hematol 29 [Suppl 1]: 20-26
15. Prenctice HG, Janossy G, Skeggs D, et al (1982) Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet 1: 700-703
16. Preti RA, Farley TJ, Fan Y, et al (1994) The combined use of soybean agglutinin and immunomagnetic beads for T lymphocyte subset depletion of bone marrow allografts: a laboratory analysis. J Hematother 3: 111-120
17. Quinones RR, Gutierez RH, Dinndorf PA, et al (1993) Extendedcycle elutriation to adjust T cell content in HLA disparate bone marrow transplantation. Blood 82: 307-317
18. Racadot E, Hervé P, Beaujean F, et al (1987) Prevention of graft versus host disease in HLA matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3 pan T monoclonal antibodies and rabbit complement. J Clin Oncol 5: 426-435
19. Reisner Y, Kapoor N, O'Reilly RJ, et al (1980) Allogeneic bone marrow transplantation using stem cells fractionated by lectins: in vitro analysis of human and monkey bone marrow cells fractionnated by sheep red blood cells and SBA. Lancet 2: 1320-1324
20. Schmitz N, Dreger P, Suttorp M, et al (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (Granulocyte colony-stimulating factor). Blood 85: 1666-1672
21. Shapiro RS, MC Clain K, Frizzera G, et al (1988) Epstein-Barr virus (EBV) associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71: 1234-1243
22. Siena S, Villa S, Bonadonna G, et al (1987) Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Transplantation 43: 421-426
23. Van der Waal E, Richel DJ, Holtkamp MJ, et al (1994) Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size. Ann Oncol 5: 795-802
24. Vartdal F, Kvalheim G, Lea TE, et al (1987) Depletion of T lymphocytes from human bone marrow. Transplantation 43: 366-71
25. Verdonck LF, Dekker AW, De Gast GC, et al (1994) Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 83: 3090-3096
26. Waldmann H, Cobbold S, Hale G (1994) What can be done to prevent graft versus host disease ? Curr Opin Immunol 6: 777-783